Promoter polymorphisms of the genes encoding tumor necrosis factor-α and interleukin-1β are associated with different subtypes of psoriasis characterized by early and late disease onset

Journal of Investigative Dermatology

Volumn 118, Issue 1, 2002, Pages 155-163

  Reich, Kristian ^a   Mössner, Rotraut ^a   König, Inke R ^a,b   Westphal, Götz ^a   Ziegler, Andreas ^a,b   Neumann, Christine ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Cytokine polymorphism; Inflammation; Skin

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

AGE; ALLELE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE OVEREXPRESSION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRON; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS VULGARIS; STIMULATION; STIMULUS RESPONSE;

EID: 0036153555     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01642.x     Document Type: Article

References (62)

1. Tumor necrosis factor-alpha gene polymorphism in psoriasis
2. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: A new therapeutic approach
3. Effects of systemic interleukin-10 therapy on psoriatic skin lesions: Histologic, immunohistologic, and molecular biology findings
4. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients
5. Cytokine gene polymorphism in human disease: On-line databases
6. Interleukin-1 receptor antagonist production by human keratinocytes
7. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease
8. Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients - Relationships with disease severity
9. The pathogenesis of psoriasis: Immunological facts and speculations
10. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis
11. Advances in the search for psoriasis susceptibility genes
12. Polymorphism in the tumor necrosis factor alpha promoter region and in the heat shock protein 70 genes are associated with malignant tumors
13. A polymorphic variation in a putative regulation box of the TNFA promoter region
14. Cytokine production by normal human monocytes. Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism
15. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance
16. Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: Evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release
17. The IL-1 system in psoriatic skin. IL-1 antagonist sphere of influence in lesional psoriatic epidermis
18. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1
19. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
20. Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specfic primers (PCR-SSP)
21. Characterization of protein complexes formed on the repressor elements of the human tumor necrosis factor alpha gene
22. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta)
23. Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes
24. Inflammatory bowel disease: No association between allele combinations of the (IL) 1β and IL-1 receptor antagonist gene polymorphisms
25. Genetics of psoriasis
26. Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris
27. A TNF-alfa promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis
28. A simple sequentially rejective multiple test procedure
29. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1β genes
30. Promoter polymorphism at -238 of the tumor necrosis factor alpha gene is not associated with early onset psoriasis when tested by the transmission disequilibrium test
31. Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: Strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region
32. Linkage disequilibrium analysis of familial psoriasis: Identification of multiple disease-associated MHC haplotypes
33. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils
34. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-α 238A promoter polymorphism
35. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
36. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: Differential effects on production and allele frequencies
37. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription
38. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor polymorphism
39. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist
40. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
41. Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomised trial
42. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease
43. Localization of psoriasis-susceptibility locus psors1 to a 60-kb interval telomeric to hla-c
44. Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sézary syndrome, but not in psoriatic plaques
45. Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate
46. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro
47. Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes - Evidence for polygenicity in man
48. Functional analysis of a new polymorphism in the human TNF alpha gene promoter
49. Adhesion molecules and IL-1 costimulate T lymphocytes in the autologous MECLR in psoriasis
50. Relative contribution of transcription and translation to the induction of tumor factor-alpha by lipopolysaccharide
51. Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis
52. Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR 2 pathway and normalization of keratinocyte maturation
53. Presence of the IL-1RA allele 2 (IL-1RN*2) is associated with enhanced IL-1β production in vitro
54. Pathogenic function of IL-1 beta in psoriasiform skin lesions of flaky skin (fsn/fsn) mice
55. Association of interleukin-1β and interleukin-1 receptor antagonist genes with disease severity in MS
56. Modified sequentially rejective multiple test procedures
57. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
58. Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis
59. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response
60. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production
61. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product
62. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation